Charles River Laboratories (CRL)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 227,347 | 617,261 | 650,975 | 589,862 | 432,729 |
| Total assets | US$ in thousands | 7,528,340 | 8,195,000 | 7,602,770 | 7,024,290 | 5,490,830 |
| Operating ROA | 3.02% | 7.53% | 8.56% | 8.40% | 7.88% |
December 31, 2024 calculation
Operating ROA = Operating income ÷ Total assets
= $227,347K ÷ $7,528,340K
= 3.02%
The operating return on assets (Operating ROA) for Charles River Laboratories has shown a fluctuating trend over the past five years. In December 2020, the Operating ROA was recorded at 7.88%, indicating that the company generated $0.0788 in operating income for every $1 of assets.
Moving on to December 2021, there was a slight improvement in the Operating ROA to 8.40%, suggesting increased efficiency in asset utilization. By December 2022, the Operating ROA further improved to 8.56%, reflecting a positive trend in the company's operational performance.
However, in December 2023, there was a noticeable decline in the Operating ROA to 7.53%, signaling potential challenges in optimizing asset productivity. The most substantial drop occurred in December 2024, with the Operating ROA plummeting to 3.02%, which may indicate decreased profitability relative to asset investment.
Overall, the fluctuating pattern in the Operating ROA suggests that Charles River Laboratories has experienced varying levels of efficiency in generating operating income from its assets over the years, highlighting the importance of closely monitoring and managing asset utilization to enhance financial performance.
Peer comparison
Dec 31, 2024